TrialBritish journal of haematology2017

The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double-blind, double-dummy, symptom study (RELIEF).

Ruben Mesa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.